B1962 for uterine cervical neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 9 Dec 2024: Trial registered, NCT06724263

The trials

NCT06724263: A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors

State
Not started
Phase
Phase 2
People
120 planned
Started
Dec 2024
Primary completion
Aug 2026
Arms
B1962
Results
None posted
  1. 9 Dec 2024: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.